Châtillon, France, February 28, 2026 DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026…
February 28, 2026 09:45 ET | Source: Cogent Biosciences, Inc. Bezuclastinib mean TSS reduction deepens to –32.0 points at 48…
KUALA LUMPUR, Malaysia, Feb. 28, 2026 (GLOBE NEWSWIRE) -- CUKTECH, a leading innovator in intelligent charging solutions, today announced the…
Tallmadge, OH, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical…
New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through…
New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- This article contains affiliate links. If a purchase is made through…
The partnership strengthens education, innovation, and patient access by combining global expertise with regional leadership in precision oncology. February 27,…
ORION CORPORATION STOCK EXCHANGE RELEASE – ANNUAL FINANCIAL REPORT 27 FEBRUARY 2026 at 11.05 EET Orion Group Financial Statement documents…
Nature Medicine Accepts Manuscript Highlighting Clinical Results from the Company’s Glioblastoma Trial February 27, 2026 04:00 ET | Source: GENENTA…
Outpatient treatment enabled under FT819-102 autoimmune basket protocol with patients now treated with FT819 off-the-shelf CAR T-cell therapy as same-day…